you are viewing a single comment's thread.
I don't like the forward PE. You should compare the forward PE with other silver miners. http://finance.yahoo.com/q?s=ssri&ql=1
At this point SSRI is still very much more of an exploration company than a producer so forward P/E is not reflective of its real value in this investor's book.With the amount of cash SSRI has it could even buy an emerging producer and I have to wonder if it isn't a take-over candidate.
Wonder whether SSRI will retain production as paste/bullion etc- instead of holding cash, in 2012; or engage in dividends; or engage in a buyout themselves or go into further discovery.If/when silver tops $50, SSRI might see a huge rise in pps, particularly with so much silver in ground.